Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection

Ivermectin, an antiparasitic drug, has been repurposed for COVID-19 treatment during the SARS-CoV-2 pandemic. Although its antiviral efficacy was confirmed early in vitro and in preclinical studies, its clinical efficacy remained ambiguous. Our purpose was to assess the efficacy of ivermectin in ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragó, Zsuzsanna, Tóth, Barbara, Szalenko-Tőkés, Ágnes, Bella, Zsolt, Dembrovszky, Fanni, Farkas, Nelli, Kiss, Szabolcs, Hegyi, Péter, Matuz, Mária, Tóth, Noémi, Hegedüs, Imre, Máthé, Domokos, Csupor, Dezső
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988599/
https://www.ncbi.nlm.nih.gov/pubmed/36879183
http://dx.doi.org/10.1007/s11357-023-00756-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988599/
https://www.ncbi.nlm.nih.gov/pubmed/36879183
http://dx.doi.org/10.1007/s11357-023-00756-y

Ejemplares similares